Hjem
Ola Myklebosts bilde

Ola Myklebost

Professor, Tel +47-5597-8495, -9008-7139
  • E-postOla.Myklebost@uib.no
  • Telefon+47 55 58 45 65+47 900 87 139
  • Besøksadresse
    Klinisk medisin II, 8 et. Laboratoriebygget
    Haukeland Sykehus
    5020 Bergen
    Rom 
    8550
  • Postadresse
    Postboks 7804
    5020 Bergen

Jeg har en ny nettside ved UiB på myklebost.uib.no. Jeg vil gjerne komme i kontakt med kandidater til PhD- eller postdocstipend!

I høst arrangerer jeg CCBIO 906, Kurs i kreftgenomikk.

Jeg er nylig begynt på UiB, tilknyttet forskningsgruppen for presisjonsonkologi, men leder fortsatt prosjekter i min gamle forskergruppe ved OUS - Radiumhospitalet, i hovdsak studier av kreft i binde- og støttevev, såkalte sarkomer. Dette er svulster med trekk fra mesenkymale vev, dvs. som stammer fra embryoets indre cellemasse. Vi har særlig konsentrert oss om osteo- og liposarkomer, svulster som ligner bein og fettvev.  Fra Bergen leder jeg to store nasjonale prosjekter der vi undersøker hvilke genskader som finnes i 9 forskjellige krefttyper, hvilke av disse som er viktige i kreftutviklingen, og om noen av dem kan brukes til å velge bedre og mer "persontilpasset" kreftbehanlding. Se mer på sidene til Norsk Kreftgenomikkonsortium (NCGC) og Norsk Sarkomkonsortium (NoSarC).

Bøker
  • Myklebost, Ola. 2000. Demper gen-håpet. Forskere advarer mot overdrevne forventninger til det som er kalt et stort gjennomslag for genforskning. -1 sider.
Tidsskriftartikler
  • Birkeland, Einar Elvbakken; Zhang, Shan; Poduval, Deepak; Geisler, Jürgen; Nakken, Sigve; Vodak, Daniel; Meza, Leonardo Zepeda; Hovig, Eivind; Myklebost, Ola; Knappskog, Stian; Lønning, Per Eystein. 2018. Patterns of genomic evolution in advanced melanoma. Nature Communications. 9:2665: 1-12. Publisert 2018-04-30. doi: 10.1038/s41467-018-05063-1
  • Gouravan, Sarina; Meza, Leonardo Zepeda; Myklebost, Ola; Stratford, Eva Wessel; Munthe, Else. 2018. Preclinical evaluation of vemurafenib as therapy for BRAFV600E mutated sarcomas. International Journal of Molecular Sciences. 19:969: 1-15. doi: 10.3390/ijms19040969
  • Kresse, Stine Henrichson; Namløs, Heidi Maria; Lorenz, Susanne; Berner, Jeanne-Marie; Myklebost, Ola; Bjerkehagen, Bodil; Meza, Leonardo Zepeda. 2018. Evaluation of commercial DNA and RNA extraction methods for high-throughput sequencing of FFPE samples. PLoS ONE. 13:e0197456: 1-12. doi: 10.1371/journal.pone.0197456
  • Løvf, Marthe; Zhao, Sen; Axcrona, Ulrika; Johannessen, Bjarne; Bakken, Anne Cathrine; Carm, Kristina Totland; Hoff, Andreas Midbøe; Myklebost, Ola; Meza, Leonardo Zepeda; Lie, Kathrine; Axcrona, Karol; Lothe, Ragnhild A; Skotheim, Rolf I. 2018. Multifocal primary prostate cancer exhibits high degree of genomic heterogeneity. European Urology. 1-8. doi: 10.1016/j.eururo.2018.08.009
  • Løvf, Marthe; Zhao, Sen; Axcrona, Ulrika; Johannessen, Bjarne; Bakken, Anne Cathrine; Carm, Kristina Totland; Hoff, Andreas Midbøe; Myklebost, Ola; Meza-Zepeda, Leonardo A; Lie, A. Kathrine; Axcrona, Karol; Lothe, Ragnhild A; Skotheim, Rolf I. 2018. High degree of genomic heterogeneity in multifocal primary prostate cancer. European Urology.
  • Misund, Kristine; Hofste op Bruinink, Davine; Coward, Eivind; Hoogenboezem, Remco; Rustad, Even Holth; Hovig, Eivind; Sundan, Anders; Myklebost, Ola; Sonneveld, Pieter; Waage, Anders. 2018. Whole-Exome and mRNA Sequencing of Multiple Myeloma Reveal Transformation to a More High-Risk and Proliferative Tumor at Relapse. Blood. doi: doi: https://doi.org/10.1182/blood-2018-99-113553
  • Nakken, Sigve; Fournous, Ghislain; Vodak, Daniel; Aasheim, Lars Birger; Myklebost, Ola; Hovig, Eivind. 2018. Personal Cancer Genome Reporter: Variant interpretation report for precision oncology. Bioinformatics. 34: 1778-1780. doi: 10.1093/bioinformatics/btx817
  • Namløs, Heidi Maria; Pedersen, Kjetil Boye; Mishkin, Skyler J.; Barøy, Tale; Lorenz, Susanne; Bjerkehagen, Bodil; Stratford, Eva Wessel; Munthe, Else; Kudlow, Brian A.; Myklebost, Ola; Meza, Leonardo Zepeda. 2018. Noninvasive Detection of ctDNA Reveals Intratumor Heterogeneity and Is Associated with Tumor Burden in Gastrointestinal Stromal Tumor. Molecular Cancer Therapeutics. 17: 2473-2480. doi: 10.1158/1535-7163.MCT-18-0174
  • Serguienko, Anastassia; Wang, Mengyu; Myklebost, Ola. 2018. Real-time vital mineralization detection and quantification during in vitro osteoblast differentiation. Biological Procedures Online. 20:14: 1-5. doi: 10.1186/s12575-018-0079-4
  • Vodak, Daniel; Lorenz, Susanne; Nakken, Sigve; Aasheim, Lars Birger; Holte, Harald; Bai, Baoyan; Myklebost, Ola; Meza, Leonardo Zepeda; Hovig, Eivind. 2018. Sample-Index Misassignment Impacts Tumour Exome Sequencing. Scientific Reports. 8:5307: 1-6. doi: 10.1038/s41598-018-23563-4
  • Aamdal, Steinar; Bentzen, Heidi Beate; Borge, Ole Johan; Erikstein, Bjørn K; Grimsgaard, Sameline; Hovig, Johannes Eivind; Myklebost, Ola; Widerberg, Ketil. 2017. Åpne Nordens grenser for forskning og behandling. Aftenposten (morgenutg. : trykt utg.).
  • Behjati, Sam; Tarpey, Patrick S.; Haase, Kerstin; Ye, Hongtao; Young, Matthew D.; Alexandrov, Ludmil B.; Farndon, Sarah J.; Collord, Grace; Wedge, David C.; Martincorena, Inigo; Cooke, Susanna L.; Davies, Helen; Mifsud, William; Lidgren, Mathias; Martin, Sancha; Latimer, Calli; Maddison, Mark; Butler, Adam P.; Teague, Jon W.; Pillay, Nischalan; Shlien, Adam; McDermott, Ultan; Futreal, P. Andrew; Baumhoer, Daniel; Zaikova, Olga; Bjerkehagen, Bodil; Myklebost, Ola; Amary, M. Fernanda; Tirabosco, Roberto; Van Loo, Peter; Stratton, Michael R.; Flanagan, Adrienne M.; Campbell, Peter J. 2017. Recurrent mutation of IGF signalling genes and distinct patterns of genomic rearrangement in osteosarcoma. Nature Communications. 8:15936: 1-8. doi: 10.1038/ncomms15936
  • Berg, Kaja Christine Graue; Eide, Peter Andreas Wold; Eilertsen, Ina Andrassy; Johannessen, Bjarne; Bruun, Jarle; Danielsen, Stine Aske; Bjørnslett, Merete Pauline; Meza, Leonardo Zepeda; Eknæs, Mette; Lind, Guro Elisabeth; Myklebost, Ola; Skotheim, Rolf I.; Sveen, Anita; Lothe, Ragnhild A. 2017. Multi-omics of 34 colorectal cancer cell lines - a resource for biomedical studies. Molecular Cancer. 16:116: 1-16. doi: 10.1186/s12943-017-0691-y
  • Engkvist, Marie Elise; Stratford, Eva Wessel; Lorenz, Susanne; Meza, Leonardo Zepeda; Myklebost, Ola; Munthe, Else. 2017. Analysis of the miR-34 family functions in breast cancer reveals annotation error of miR-34b. Scientific Reports. 7:9655: 1-10. doi: 10.1038/s41598-017-10189-1
  • Helland, Åslaug; Brustugun, Odd Terje; Nakken, Sigve; Halvorsen, Ann Rita; Dønnem, Tom; Bremnes, Roy M.; Busund, Lill-Tove; Sun, Jinchang; Lorenz, Susanne; Solberg, Steinar; Jørgensen, Lars Hilmar; Vodak, Daniel; Myklebost, Ola; Hovig, Eivind; Meza, Leonardo Zepeda. 2017. High number of kinome-mutations in non-small cell lung cancer is associated with reduced immune response and poor relapse-free survival. International Journal of Cancer. 141: 184-190. doi: 10.1002/ijc.30726
  • Namløs, Heidi Maria; Zaikova, Olga; Bjerkehagen, Bodil; Vodak, Daniel; Hovig, Johannes Eivind; Myklebost, Ola; Pedersen, Kjetil Boye; Meza, Leonardo Zepeda. 2017. Use of liquid biopsies to monitor disease progression in a sarcoma patient: a case report. BMC Cancer. 17:29: 1-6. doi: 10.1186/s12885-016-2992-8
  • Rustad, Even Holth; Coward, Eivind; Skytøen, Emilie R; Misund, Kristine; Holien, Toril; Standal, Therese; Børset, Magne; Beisvag, Vidar; Myklebost, Ola; Meza, Leonardo Zepeda; Hong, Yan Dai; Sundan, Anders; Waage, Anders. 2017. Monitoring multiple myeloma by quantification of recurrent mutations in serum. Haematologica. 102: 1266-1272. doi: 10.3324/haematol.2016.160564
  • Serguienko, Anastassia; Hanes, Robert; Grad, Iwona; Wang, Mengyu; Myklebost, Ola; Munthe, Else. 2017. PP2A regulatory subunit b55γ is a gatekeeper of osteoblast maturation and lineage maintenance. Stem Cells and Development. 26: 1375-1383. doi: 10.1089/scd.2017.0129
  • Sveen, Anita; Johannessen, Bjarne; Tengs, Torstein; Danielsen, Stine Aske; Eilertsen, Ina Andrassy; Lind, Guro Elisabeth; Berg, Kaja Christine Graue; Leithe, Edward; Meza, Leonardo Zepeda; Domingo, Enric; Myklebost, Ola; Kerr, David; Tomlinson, Ian; Nesbakken, Arild; Skotheim, Rolf I.; Lothe, Ragnhild A. 2017. Multilevel genomics of colorectal cancers with microsatellite instability – clinical impact of JAK1 mutations and consensus molecular subtype 1. Genome Medicine. 9. doi: 10.1186/s13073-017-0434-0
  • Ballinger, Mandy L.; Goode, David L.; Ray-Coquard, Isabelle; James, Paul A.; Mitchell, Gillian; Niedermayr, Eveline; Puri, Ajay; Schiffman, Joshua D.; Dite, Gillian S.; Cipponi, Arcadi; Maki, Robert G.; Brohl, Andrew S.; Myklebost, Ola; Stratford, Eva Wessel; Lorenz, Susanne; Ahn, Sung-Min; Ahn, Jin-Hee; Kim, Jeong Eun; Shanley, Sue; Beshay, Victoria; Randall, Robert Lor; Judson, Ian; Seddon, Beatrice; Campbell, Ian G.; Young, Mary-Anne; Sarin, Rajiv; Blay, Jean-Yves; O'Donoghue, Seán I.; Thomas, David M. 2016. Monogenic and polygenic determinants of sarcoma risk: an international genetic study. The Lancet Oncology. 17: 1261-1271. doi: 10.1016/S1470-2045(16)30147-4
  • Barøy, Tale; Chilamakuri, Chandra Sekhar Reddy; Lorenz, Susanne; Sun, Jinchang; Bruland, Øyvind; Myklebost, Ola; Meza-Zepeda, Leonardo. 2016. Genome analysis of osteosarcoma progression samples identifies FGFR1 overexpression as a potential treatment target and CHM as a candidate tumor suppressor gene. PLoS ONE. doi: 10.1371/journal.pone.0163859
  • Halvorsen, Ann Rita; Silwal-Pandit, Laxmi; Meza, Leonardo Zepeda; Vodak, Daniel; Vu, Phuong Ngoc Thi; Sagerup, Camilla Maria Troøien; Hovig, Johannes Eivind; Myklebost, Ola; Børresen-Dale, Anne-Lise; Brustugun, Odd Terje; Helland, Åslaug. 2016. TP53 mutation spectrum in smokers and never smoking lung cancer patients. Frontiers in Genetics. 7. doi: 10.3389/fgene.2016.00085
  • Hanes, Robert; Grad, Iwona; Lorenz, Susanne; Stratford, Eva Wessel; Munthe, Else; Chilamakuri, Chandra Sekhar Reddy; Meza, Leonardo Zepeda; Myklebost, Ola. 2016. Preclinical evaluation of potential therapeutic targets in dedifferentiated liposarcoma. OncoTarget. 7: 54583-54595. doi: 10.18632/oncotarget.10518
  • Kager, Leo; Whelan, Jeremy; Dirksen, U; Hassan, Bass; Anninga, Jacob; Bennister, L; Bovée, Judith; Brennan, B. A.; Broto, JM; Brugieres, L; Cleton-Jansen, Anne-Marie; Copland, C; Dutour, A; Fagioli, F; Ferrari, S; Fiocco, M; Fleuren, E; Gaspar, N; Gelderblom, Hans; Gerrand, C; Gerss, J; Gonzato, O; van der Graaf, W; Hecker-Nolting, S; Herrero-Martin, D; Klco-Brosius, S; Kovar, H; Ladenstein, R; Lancia, C; LeDeley, MC; McCabe, MG; Metzler, M; Myklebost, Ola; Nathrath, Michaela; Picci, Piero; Potratz, J; Redini, F; Richter, GH; Reinke, D; Rutkowski, P; Scotlandi, Katia; Strauss, S; Thomas, David M; Tirado, OM; Tirode, F; Vassal, GH; Bielack, Stefan S. 2016. The ENCCA-WP7/EuroSarc/EEC/PROVABES/EURAMOS 3rd European Bone Sarcoma Networking Meeting/Joint Workshop of EU Bone Sarcoma Translational Research Networks; Vienna, Austria, September 24-25, 2015. Workshop Report. Clinical sarcoma research. doi: 10.1186/s13569-016-0043-5
  • Lorenz, Susanne; Barøy, Tale; Sun, Jinchang; Nome, Torfinn; Vodak, Daniel; Bryne, Jan Christian; Håkelien, Anne-Mari; Fernandez-Cuesta, Lynnette; Möhlendick, B; Rieder, H; Szuhai, K; Zaikova, Olga; Ahlquist, Terje Cruickshank; Thomassen, Gard O Sundby; Skotheim, Rolf Inge; Lothe, Ragnhild A; Tarpey, P; Campbell, P.; Flanagan, A; Myklebost, Ola; Meza, Leonardo Zepeda. 2016. Unscrambling the genomic chaos of osteosarcoma reveals extensive transcript fusion, recurrent rearrangements and frequent novel TP53 aberrations. OncoTarget. 7: 5273-5288. doi: 10.18632/oncotarget.6567
  • Sandhu, Vandana; Wedge, David C.; Lothe, Inger Marie Bowitz; Labori, Knut Jørgen; Dentro, Stefan C.; Buanes, Trond; Skrede, Martina; Larsen, Astrid Marie; Munthe, Else; Myklebost, Ola; Lingjærde, Ole Christian; Børresen-Dale, Anne-Lise; Andersen, Tone Ikdahl; Van Loo, Peter; Nord, Silje; Kure, Elin H. 2016. The genomic landscape of pancreatic and periampullary adenocarcinoma. Cancer Research. 76: 5092-5102. doi: 10.1158/0008-5472.CAN-16-0658
  • Ju, Y.S; Tubio, J.M.C; Mifsud, W; Davies, H.R; Fu, B; Ramakrishna, M; Li, Y; Yates, L; Gundem, G; Tarpey, P.S; Behjati, S; Papaemmanuil, E; Martin, S; Fullam, A; Gerstung, M; Stratton, M.R; Campbell, P.M; Nik-Zainal, S; Yang, F; McDermott, U; Thompson, A.M; Richardson, A.L; Purdie, C.A; Thomas, G; Desmedt, C; Lakhani, S.R; Eeles, R; Cooper, C; Neal, D.E; Foster, C; Flanagan, A.M; Myklebost, Ola; Eyfjörd, J.E; Børresen-Dale, A.L.; Vincent-Salomon, A; Knappskog, S; Martens, J.W.M; Span, P.N; Aparicio, S; van’t Veer, L.J; Tan, B.K.T; Borg, Å; Tutt, A; Ta, M; Lee, M; Caldas, C; Green, A.R; Nangalia, J; ICGC, Breast Cancer Working Gro; ICGC, Bone Cancer Working Group; ICGC, Prostate Cancer Working Group. 2015. Frequent somatic transfer of mitochondrial DNA into the nuclear genome of human cancer cells. Genome Research.
  • Kanojia, Deepika; Nagata, Yasunobu; Garg, Manoj; Lee, Dhong Hyun; Sato, Aiko; Yoshida, Kenichi; Sato, Yusuke; Sanada, Masashi; Mayakonda, Anand; Bartenhagen, Christoph; Klein, Hans-Ulrich; Doan, Ngan B.; Said, Jonathan W.; Mohith, Surana; Gunasekar, Swetha; Shiraishi, Yuichi; Chiba, Kenichi; Tanaka, Hiroko; Miyano, Satoru; Myklebost, Ola; Yang, Henry; Dugas, Martin; Meza, Leonardo Zepeda; Silberman, Allan W.; Forscher, Charles; Tyner, Jeffrey W.; Ogawa, Seishi; Koeffler, H. Phillip. 2015. Genomic landscape of liposarcoma. OncoTarget. 6: 42429-42444. doi: 10.18632/oncotarget.6464
  • Ljøsne, Isabelle Budin; Bentzen, Heidi Beate; Solbakk, Jan Helge; Myklebost, Ola. 2015. Genomsekvensering i forskning krever ny tilnærming til samtykke. Tidsskrift for Den norske legeforening. 135: 2031-2032. doi: 10.4045/tidsskr.15.0944
  • Myklebost, Ola. 2015. Personalized cancer therapy for soft tissue sarcomas: progress and pitfalls. Personalized Medicine. 12: 593-602. doi: 10.2217/pme.15.20
  • Myklebost, Ola. 2015. Norwegian Cancer Genomics Consortium: A platform for research on personalized cancer medicine in a public health system. Drug Discovery Today. 20: 1419-1421. doi: 10.1016/j.drudis.2015.10.003
  • Myklebost, Ola; Lothe, Ragnhild A; Gjertsen, Bjørn Tore; Lønning, Per Eystein. 2015. Bør hver kreftpasient bli et eget forskningsprosjekt? Aftenposten (morgenutg. : trykt utg.). Publisert 2015-08-12.
  • Naderi, Elin Hallan; Skah, Seham; Ugland, Hege Katrin; Myklebost, Ola; Sandnes, Dagny Lise; Torgersen, Maria Lyngaas; Josefsen, Dag; Ruud, Ellen; Naderi, Soheil; Blomhoff, Heidi Kiil. 2015. Bone marrow stroma-derived PGE<sub>2</sub> protects BCP-ALL cells from DNA damage-induced p53 accumulation and cell death. Molecular Cancer. 14. doi: 10.1186/s12943-014-0278-9
  • Rustad, Even Holth; Dai, Hong Yan; Hov, Håkon; Coward, Eivind; Beisvag, Vidar; Myklebost, Ola; Hovig, Johannes Eivind; Nakken, Sigve; Vodak, Daniel; Meza, Leonardo Zepeda; Sandvik, Arne Kristian; Wader, Karin Fahl; Misund, Kristine; Sundan, Anders; Aarset, Harald; Waage, Anders. 2015. BRAF V600E mutation in early-stage multiple myeloma: good response to broad acting drugs and no relation to prognosis. Blood Cancer Journal. 5:e299: 1-7. doi: 10.1038/bcj.2015.24
  • Safavi, S; Järnum, S; Vannas, C; Udane, S; Jonasson, E; Tomic, TT; Grundevik, P; Fagman, H; Hansson, M; Kalender, Z; Jauhiainen, A; Dolatabadi, S; Stratford, Eva Wessel; Myklebost, Ola; Eriksson, M; Stock, ES; Ståhlberg, S; Åman, P. 2015. HSP90 inhibition blocks ERBB3 and RET phosphorylation in myxoid/round cell liposarcoma and causes massive cell death in vitro and in vivo. OncoTarget. 7: 433-445. doi: 10.18632/oncotarget.6336
  • Serguienko, Anastassia; Grad, Iwona; Wennerstrøm, Anna; Meza, Leonardo Zepeda; Thiede, Bernd; Stratford, Eva Wessel; Myklebost, Ola; Munthe, Else. 2015. Metabolic reprogramming of metastatic breast cancer and melanoma by Let-7a microRNA. OncoTarget. 6: 2451-2465. doi: 10.18632/oncotarget.3235
  • Anninga, Jakob K.; Cleton-Jansen, Anne-Marie; Hassan, Bass; Amary, M. Fernanda; Baumhoer, Daniel; Blay, Jean-Yves; Brugieres, Laurence; Ferrari, Stefano; Jürgens, Heribert T.; Kempf-Bielack, Beate; Kovar, Heinrich; Myklebost, Ola; Nathrath, Michaela; Picci, Piero; Riegman, Peter; Schilham, Marco W.; Soliman, Ranin; Stark, Dan P.; Strauss, Sandra; Syde, Matthew; Tarpey, Patrick; Thomas, David; Whelan, Jeremy; Wilhelm, Miriam; Zamzam, Manal; Gelderblom, Hans; Bielack, Stefan S. 2014. Workshop Report on the 2nd Joint ENCCA/EuroSARC European Bone Sarcoma Network Meeting: Integration of Clinical Trials with Tumour Biology. Clinical sarcoma research. 4. Publisert 2014-05-01. doi: 10.1186/2045-3329-4-4
  • Barøy, Tale; Kresse, Stine Henrichson; Skårn, Magne Nordang; Stabell, Marianne; Russell, Castro; Lauvrak, Silje Anett Ugland; Llombart-Bosch, Antonio; Myklebost, Ola; Meza, Leonardo Zepeda. 2014. Reexpression of LSAMP inhibits tumor growth in a preclinical osteosarcoma model. Molecular Cancer. 13. doi: 10.1186/1476-4598-13-93
  • Chilamakuri, Chandra Sekhar Reddy; Lorenz, Susanne; Madoui, Mohammed-Amin; Vodak, Daniel; Sun, Jinchang; Hovig, Johannes Eivind; Myklebost, Ola; Meza, Leonardo Zepeda. 2014. Performance comparison of four exome capture systems for deep sequencing. BMC Genomics. 15. doi: 10.1186/1471-2164-15-449
  • Garsed, Dale W.; Marshall, Owen J.; Corbin, Vincent D.A.; Hsu, Arthur; DiStefano, Leon; Schröder, Jan; Li, Jason; Feng, Zhi-Ping; Kim, Bo W.; Kowarsky, Mark; Lansdell, Ben; Brookwell, Ross; Myklebost, Ola; Meza, Leonardo Zepeda; Holloway, Andrew J.; Pedeutour, Florence; Choo, K.H. Andy; Damore, Michael A.; Deans, Andrew J.; Papenfuss, Anthony T.; Thomas, David M. 2014. The Architecture and Evolution of Cancer Neochromosomes. Cancer Cell. 26: 653-667. doi: 10.1016/j.ccell.2014.09.010
  • Håkelien, Anne-Mari; Bryne, Jan Christian; Harstad, Kristine Gjul; Lorenz, Susanne; Paulsen, Jonas; Sun, Jinchang; Mikkelsen, Tarjei S.; Myklebost, Ola; Meza, Leonardo Zepeda. 2014. The regulatory landscape of osteogenic differentiation. Stem Cells. 32: 2780-2793. doi: 10.1002/stem.1759
  • Skårn, Magne Nordang; Noordhuis, Paul; Wang, Mengyu; Veuger, Maria Johanna; Kresse, Stine Henrichson; Egeland, Eivind Valen; Micci, Francesca; Namløs, Heidi Maria; Håkelien, Anne-Mari; Olafsrud, Solveig Mjelstad; Lorenz, Susanne; Haraldsen, Guttorm; Kvalheim, Gunnar; Meza, Leonardo Zepeda; Myklebost, Ola. 2014. Generation and characterization of an immortalized human mesenchymal stromal cell line. Stem Cells and Development. 23: 2377-2389. doi: 10.1089/scd.2013.0599
  • Stratford, Eva Wessel; Daffinrud, Jeanette L.; Munthe, Else; Castro, Russell; Waaler, Jo; Krauss, Stefan; Myklebost, Ola. 2014. The tankyrase-specific inhibitor JW74 affects cell cycle progression and induces apoptosis and differentiation in osteosarcoma cell lines. Cancer Medicine. 3: 36-46. doi: 10.1002/cam4.170
  • Stratford, Eva Wessel; Myklebost, Ola. 2014. TRAP1 is a novel interaction partner of PML, localised with PML in nuclear bodies and relocating with PML to the cytoplasm following stress. Annual Research & Review in Biology. 4: 3026-3036. Publisert 2014-05-31.
  • Tubio, JMC; Li, Y; Ju, YS; Martincorena, I; Cooke, SL; Tojo, M; Gundem, G; Pipinikas, CP; Zamora, J; Raine, K; Menzies, A; Roman-Garcia, P; Gerstung, M; Shlien, A; Tarpey, PS; Papaemmanuil, E; Knappskog, S; Van Loo, P; Ramakrishna, M; Davies, HR; Marshall, J; Wedge, DC; Teague, JW; Butler, AP; Nik-Zainal, S; Alexandrov, L; Behjati, S; Yates, LR; Bolli, N; Mudie, L; Hardy, C; Martin, S; McLaren, S; O'Meara, S; Andreson, E; Maddison, M; Gamble, S; ICGC, Breast Cancer Group; ICGC, Bone Cancer Group; ICGC, Prostate Cancer Group; Foster, C; Warren, AY; Whitaker, H; Brewer, D; Eeles, R; Cooper, C; Neal, D; Lynch, AG; Visakorpi, T; Isaacs, WB; van't Veer, L; Caldas, C; Desmedt, C; Sotiriou, C; Aparicio, A; Foekens, JA; Eyfjord, JE; Lakhani, SR; Thomas, G; Myklebost, Ola; Span, PN; Børresen-Dale, Anne-Lise; Richardson, AL; van de Vijver, M; Vincent-Salomon, A; Van Den Eynden, GG; Flanagan, AM; Futreal, PA; Janes, SM; Bova, GS; Stratton, MR; McDermott, U; Campbell, PJ. 2014. Extensive transduction of non-reptitive DNA mediated by L1 retrotransposition in cancer genomes. Science. 345: 1251343-1251343. doi: 10.1126/science.1251343
  • Tubio, José M.C.; Li, Yilong; Ju, Young Seok; Martincorena, Inigo; Cooke, Susanna L.; Tojo, Marta; Gundem, Gunes; Pipinikas, Christodoulos P.; Zamora, Jorge; Raine, Keiran; Menzies, Andrew; Roman-Garcia, Pablo; Fullam, Anthony; Gerstung, Moritz; Shlien, Adam; Tarpey, Patrick S.; Papaemmanuil, Elli; Knappskog, Stian; Van Loo, Peter; Ramakrishna, Manasa; Davies, Helen R.; Marshall, John; Wedge, David C.; Teague, Jon W.; Butler, Adam P.; Nik-Zainal, Serena; Alexandrov, Ludmil; Behjati, Sam; Yates, Lucy R.; Bolli, Niccolò; Mudie, Laura; Hardy, Claire; Martin, Sancha; McLaren, Stuart; O'Meara, Sarah; Anderson, Elizabeth; Maddison, Mark; Gamble, Stephen; Foster, Christopher; Warren, Anne Y.; Whitaker, Hayley; Brewer, Daniel; Eeles, Rosalind; Cooper, Colin; Neal, David; Lynch, Andy G.; Visakorpi, Tapio; Isaacs, William B.; Van't Veer, Laura; Caldas, Carlos; Desmedt, Christine; Sotiriou, Christos; Aparicio, Sam; Foekens, John A.; Eyfjörd, Jórunn Erla; Lakhani, Sunil R.; Thomas, Gilles; Myklebost, Ola; Span, Paul N.; Børresen-Dale, Anne-Lise; Richardson, Andrea L.; van de Vijver, Marc; Vincent-Salomon, Anne; Van den Eynden, Gert G.; Flanagan, Adrienne M.; Futreal, P. Andrew; Janes, Sam M.; Bova, G. Steven; Stratton, Michael R.; McDermott, Ultan; Campbell, Peter J. 2014. Extensive transduction of nonrepetitive DNA mediated by L1 retrotransposition in cancer genomes. Science. 345. doi: 10.1126/science.1251343
  • Wennerstrøm, Anna; Lothe, Inger Marie Bowitz; Sandhu, Vandana; Kure, Elin H.; Myklebost, Ola; Munthe, Else. 2014. Generation and Characterisation of Novel Pancreatic Adenocarcinoma Xenograft Models and Corresponding Primary Cell Lines. PLoS ONE. 9. 12 sider. doi: 10.1371/journal.pone.0103873
  • Behjati, Sam; Tarpey, Patrick S.; Presneau, Nadège; Scheipl, Susanne; Pillay, Nischalan; Van Loo, Peter; Wedge, David C.; Cooke, Susanna L.; Gundem, Gunes; Davies, Helen; Nik-Zainal, Serena; Martin, Sancha; McLaren, Stuart; Goodie, Victoria; Robinson, Ben; Butler, Adam; Teague, Jon W.; Halai, Dina; Khatri, Bhavisha; Myklebost, Ola; Baumhoer, Daniel; Jundt, Gernot; Hamoudi, Rifat; Tirabosco, Roberto; Amary, M. Fernanda; Futreal, P. Andrew; Stratton, Michael; Campbell, Peter J.; Flanagan, Adrienne M.; Stratton, Michael R.; Campbell, PJ; Flanagan, AM. 2013. Distinct H3F3A and H3F3B driver mutations define chondroblastoma and giant cell tumor of bone. Nature Genetics. 45: 1479-U105. doi: 10.1038/ng.2814
  • Bianchini, Laurence; Birtwisle, Loic; Saada, Esma; Bazin, Audrey; Long, Elodie; Roussel, Jean-Francois; Michiels, J-F.; Forest, Fabien; Dani, Christian; Myklebost, Ola; Birtwisle-Peyrottes, Isabelle; Pedeutour, Florence. 2013. Identification of PPAP2B as a novel recurrent translocation partner gene of HMGA2 in lipomas. Genes, Chromosomes and Cancer. 52: 580-590. doi: 10.1002/gcc.22055
  • Doorn, Joyce; Fernandes, Hugo A.M.; Le, Bach Q.; van de Peppel, Jeroen; van Leeuwen, Johannes P.T.M.; De Vries, Margreet R.; Aref, Zeen; Quax, Paul H.A.; Myklebost, Ola; Saris, Daniel B.F.; van Blitterswijk, Clements A.; de Boer, Jan. 2013. A small molecule approach to engineering vascularized tissue. Biomaterials. 34: 3053-3063. doi: 10.1016/j.biomaterials.2012.12.037
  • Kuijjer, Marieke L.; Peterse, Elisabeth FP; van den Akker, BEWM; Briaire-de Bruijn, IH; Serra, Massimo; Meza-Zepeda, Leonardo Andrés; Myklebost, Ola; Hassan, A Bassim; Hogendoorn, Pancras C. W.; Cleton-Jansen, Anne-Marie. 2013. IR/IGF1R signaling as potential target for treatment of high-grade osteosarcoma. BMC Cancer. 13. 9 sider. doi: 10.1186/1471-2407-13-245
  • Lauvrak, Silje Anett Ugland; Munthe, Else; Kresse, Stine Henrichson; Stratford, Eva Wessel; Namløs, Heidi Maria; Meza-Zepeda, Leonardo Andrés; Myklebost, Ola. 2013. Functional characterization of osteosarcoma cell lines and identification of mRNAs and miRNAs associated with aggressive cancer phenotypes. British Journal of Cancer. 109: 2228-2236. doi: 10.1038/bjc.2013.549
  • Nome, Torfinn; Thomassen, Gard O Sundby; Bruun, Jarle; Ahlquist, Terje Cruickshank; Bakken, Anne Cathrine; Hoff, Andreas Midbøe; Rognum, Torleiv Ole; Nesbakken, Arild; Lorenz, Susanne; Sun, Jinchang; Barros-Silva, João D.; Lind, Guro Elisabeth; Myklebost, Ola; Teixeira, Manuel; Meza-Zepeda, Leonardo Andrés; Lothe, Ragnhild A; Skotheim, Rolf Inge. 2013. Common fusion transcripts identified in colorectal cancer cell lines by high throughput RNA sequencing. Translational Oncology. 6: 546-553. doi: 10.1593/tlo.13457
  • Ohnstad, Hege Oma; Castro, Russell; Sun, Jinchang; Heintz, Karen Marie; Vassilev, LT; Bjerkehagen, Bodil; Kresse, Stine Henrichson; Meza-Zepeda, Leonardo Andrés; Myklebost, Ola. 2013. Correlation of TP53 and MDM2 genotypes with response to therapy in sarcoma. Cancer. 119: 1013-1022. doi: 10.1002/cncr.27837
  • Sandberg, Cecilie; Altschuler, Gabriel; Jeong, Jieun; Strømme, Kirsten Kierulf; Stangeland, Biljana; Murrell, Wayne; Grasmo-Wendler, Unn-Hilde; Myklebost, Ola; Helseth, Eirik; Vik-Mo, Einar O.; Hide, Winston; Langmoen, Iver Arne. 2013. Comparison of glioma stem cells to neural stem cells from the adult human brain identifies dysregulated Wnt- signaling and a fingerprint associated with clinical outcome. Experimental Cell Research. 319: 2230-2243. doi: 10.1016/j.yexcr.2013.06.004
  • Skårn, Magne; Barøy, Tale; Stratford, Eva Wessel; Myklebost, Ola. 2013. Epigenetic Regulation and Functional Characterization of MicroRNA-142 in Mesenchymal Cells. PLoS ONE. 8. Publisert 2013-11-13. doi: 10.1371/journal.pone.0079231
  • Stratford, Eva Wessel; Bostad, Monica; Russell, Castro; Skarpen, Ellen; Berg, Kristian; Høgset, Anders; Myklebost, Ola; Selbo, Pål Kristian. 2013. Photochemical internalization of CD133-targeting immunotoxins efficiently depletes sarcoma cells with stem-like properties and reduces tumorigenicity. Biochimica et Biophysica Acta - General Subjects. 1830: 4235-4243. doi: 10.1016/j.bbagen.2013.04.033
  • Kresse, Stine Henrichson; Meza, Leonardo Zepeda; Machado, Isidro; Llombart-Bosch, Antonio; Myklebost, Ola. 2012. Preclinical xenograft models of human sarcoma show nonrandom loss of aberrations. Cancer. 118: 558-570. doi: 10.1002/cncr.26276
  • Kresse, Stine Henrichson; Rydbeck, Halfdan; Skårn, Magne; Namløs, Heidi Maria; Barragan Polania, Ana H.; Cleton-Jansen, Anne-Marie; Serra, Massimo; Liestøl, Knut; Hogendoorn, Pancras C. W.; Hovig, Eivind; Myklebost, Ola; Meza-Zepeda, Leonardo Andrés. 2012. Integrative Analysis Reveals Relationships of Genetic and Epigenetic Alterations in Osteosarcoma. PLoS ONE. 7. 20 sider. doi: 10.1371/journal.pone.0048262
  • Kuijjer, Marieke L.; Rydbeck, Halfdan; Kresse, Stine Henrichson; Buddingh, Emilie P.; Lid, Ana Heslanyeth Barragan Polani; Roelofs, Helene; Bürger, Horst; Myklebost, Ola; Hogendoorn, Pancras C. W.; Meza, Leonardo Zepeda; Cleton-Jansen, Anne-Marie. 2012. Identification of osteosarcoma driver genes by integrative analysis of copy number and gene expression data. Genes, Chromosomes and Cancer. 51: 696-706. doi: 10.1002/gcc.21956
  • Namløs, Heidi Maria; Kresse, Stine Henrichson; Muller, Christoph Rainer; Henriksen, Jørn; Holdhus, Rita; Sæter, Gunnar; Bruland, Øyvind; Bjerkehagen, Bodil; Steen, Vidar Martin; Myklebost, Ola. 2012. Global gene expression profiling of human osteosarcomas reveals metastasis-associated chemokine pattern. Sarcoma. 12 sider. doi: 10.1155/2012/639038
  • Namløs, Heidi Maria; Meza-Zepeda, Leonardo Andrés; Barøy, Tale; Østensen, Ingrid Helene Garmann; Kresse, Stine Henrichson; Kuijjer, Marieke L.; Serra, Massimo; Bürger, Horst; Cleton-Jansen, Anne-Marie; Myklebost, Ola. 2012. Modulation of the Osteosarcoma Expression Phenotype by MicroRNAs. PLoS ONE. 7. 12 sider. doi: 10.1371/journal.pone.0048086
  • Skotheim, Rolf Inge; Meza-Zepeda, Leonardo Andrés; Hovig, Eivind; Lønning, Per Eystein; Lothe, Ragnhild A; Myklebost, Ola. 2012. Genomsekvensering for persontilpasset kreftbehandling. Tidsskrift for Den norske legeforening. 132: 2406-2408. doi: 10.4045/tidsskr.12.0784
  • Skotheim, Rolf Inge; Nome, Torfinn; Thomassen, Gard O Sundby; Johannessen, Bjarne; Bakken, Anne Cathrine; Bruun, Jarle; Ahlquist, Terje Cruickshank; Meza-Zepeda, L. A.; Myklebost, Ola; Lothe, Ragnhild A. 2012. Identification of Fusion Transcripts in Colorectal Cancer by Combined RNA-seq and Exon Microarray Analyses. European Journal of Cancer. 48: S121-S121.
  • Skårn, Magne; Namløs, Heidi Maria; Noordhuis, Paul; Wang, Mengyu; Meza, Leonardo Zepeda; Myklebost, Ola. 2012. Adipocyte Differentiation of Human Bone Marrow-Derived Stromal Cells Is Modulated by MicroRNA-155, MicroRNA-221, and MicroRNA-222. Stem Cells and Development. 21: 873-883. doi: 10.1089/scd.2010.0503
  • Stratford, Eva Wessel; Castro, Russell; Daffinrud, Jeanette L.; Skårn, Magne; Lauvrak, Silje Anett Ugland; Munthe, Else; Myklebost, Ola. 2012. Characterization of liposarcoma cell lines for preclinical and biological studies. Sarcoma. doi: 10.1155/2012/148614
  • Thomas, DM; Wilhelm, M; Cleton-Jansen, Anne-Marie; Dirksen, U; Entz-Werlé, N; Gelderblom, H; Hassan, B; Jurgens, H.; Koster, J; Kovar, H; Lankester, AC; Lewis, IJ; Myklebost, Ola; Nathrat, MHM; Picci, P; Whelan, Jeremy; Hogendoorn, Pancras C. W.; Bielack, Stefan. 2012. Workshop report on the European Bone Sarcoma Networking Meeting: integration of clinical trials with tumor biology. Journal of Adolescent and Young Adult Oncology. doi: 10.1089/jayao.2012.005
  • Buddingh, EP; Kuijjer, ML; Duim, RL; Bürger, Horst; Agelopoulos, KL; Myklebost, Ola; Serra, Massimo; Hogendoorn, Pancras C. W.; Lankester, Arjan C.; Cleton-Jansen, Anne-Marie. 2011. Metastasis suppression by tumor-infiltrating macrophages in high-grade osteosarcoma. Clinical Cancer Research. 17: 2110-2119. doi: DOI:10.1158/1078-0432.CCR-10-2047
  • Buddingh, Emilie P.; Kuijjer, Marieke L.; Duim, Ronald A.J.; Bürger, Horst; Agelopoulos, Konstantin; Myklebost, Ola; Serra, Massimo; Mertens, Fredrik; Hogendoom, Pancras C.W.; Lankester, Arjan C.; Cleton-Jansen, Anne-Marie. 2011. Tumor-Infiltrating Macrophages Are Associated with Metastasis Suppression in High-Grade Osteosarcoma: A Rationale for Treatment with Macrophage Activating Agents. Clinical Cancer Research. 17: 2110-2119. doi: 10.1158/1078-0432.CCR-10-2047
  • Hjortland, Geir Olav; Meza, Leonardo Zepeda; Beiske, Klaus; Ree, Anne Hansen; Tveito, Siri; Høifødt, Hanne Kleppe; Bøhler, Per J.; Hole, Knut Håkon; Myklebost, Ola; Fodstad, Øystein; Smeland, Sigbjørn; Hovig, Eivind. 2011. Genome wide single cell analysis of chemotherapy resistant metastatic cells in a case of gastroesophageal adenocarcinoma. BMC Cancer. 11. 8 sider. doi: 10.1186/1471-2407-11-455
  • Kresse, Stine Henrichson; Meza, Leonardo Zepeda; Machado, Isidro; Llombart-Bosch, Antonio; Myklebost, Ola. 2011. Genomic validation of preclinical xenograft models of human sarcoma reveals recurrent loss of aberrations. Cancer. 118: 558-570. doi: 10.1002/cncr.26276
  • Kuijjer, Marieke L.; Namløs, Heidi Maria; Hauben, Esther I.; Machado, Isidro; Kresse, Stine Henrichson; Serra, Massimo; Llombart-Bosch, Antonio; Hogendoorn, Pancras C. W.; Meza, Leonardo Zepeda; Myklebost, Ola; Cleton-Jansen, Anne-Marie. 2011. mRNA expression profiles of primary high-grade central osteosarcoma are preserved in cell lines and xenografts. BMC Medical Genomics. 4. 11 sider. doi: 10.1186/1755-8794-4-66
  • Ohnstad, Hege Oma; Paulsen, Erik Braarød; Noordhuis, Paul; Berg, Marianne; Lothe, Ragnhild A; Vassilev, Lyubomir T.; Myklebost, Ola. 2011. MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines. BMC Cancer. 11. 11 sider. doi: 10.1186/1471-2407-11-211
  • Skårn, Magne; Namløs, Heidi Maria; Noordhuis, Paul; Wang, Mengyu; Meza, Leonardo Zepeda; Myklebost, Ola. 2011. Adipocyte Differentiation of Immortalized Human Bone Marrow-Derived Stromal Cells is Modulated by microRNA-155, microRNA-221 and microRNA-222. Stem Cells and Development. doi: 10.1089/scd.2010.0503
  • Stratford, Eva Wessel; Castro, R; Wennerström, Anna Berit; Holm, Ruth; Munthe, Else; Lauvrak, Silje Anett Ugland; Bjerkehagen, Bodil; Myklebost, Ola. 2011. Combined ALDH and CD133 expression defines a stem-like cancer cell population in liposarcoma xenograft. Clinical sarcoma research. 1: 8.
  • Baroy, T; Hopmeier, Dahlia; Kresse, Stine Henrichson; Myklebost, Ola; Meza-Zepeda, Leonardo Andrés. 2010. Characterisation of LSAMP, a novel candidate tumour suppressor gene in osteosarcomas. European Journal of Cancer. 8: 169-169.
  • Eide, Marianne Brodtkorb; Liestøl, Knut; Lingjærde, Ole Christian; Hystad, Marit Elise; Kresse, Stine Henrichson; Meza, Leonardo Zepeda; Myklebost, Ola; Trøen, Gunhild; Aamot, Hege; Holte, Harald; Smeland, Erlend B; Delabie, Jan. 2010. Genomic alterations reveal potential for higher grade transformation in follicular lymphoma and confirm parallel evolution of tumor cell clones. Blood. 116: 1489-1497. doi: 10.1182/blood-2010-03-272278
  • Henriksen, Jørn; Stabell, Marianne; Meza, Leonardo Zepeda; Lauvrak, Silje Anett Ugland; Kassem, Moustapha; Myklebost, Ola. 2010. Identification of target genes for wild type and truncated HMGA2 in mesenchymal stem-like cells. BMC Cancer. 10. 14 sider. doi: 10.1186/1471-2407-10-329
  • Kresse, Stine Henrichson; Ohnstad, Hege Oma; Bjerkehagen, Bodil; Myklebost, Ola; Meza-Zepeda, Leonardo A.; Meza, Leonardo Zepeda. 2010. DNA Copy Number Changes in Human Malignant Fibrous Histiocytomas by Array Comparative Genomic Hybridisation. PLoS ONE. 5. 10 sider. doi: 10.1371/journal.pone.0015378
  • Kresse, Stine Henrichson; Rydbeck, Halfdan; Heslanyeth Barragan Polania, Ana; Duim, Ronald A.J.; Cleton-Jansen, Anne-Marie; Myklebost, Ola; Meza, Leonardo Zepeda. 2010. Integrative analysis of genome-wide genetic and epigenetic changes in human osteosarcomas. European Journal of Cancer. 8: 200-200.
  • Kresse, Stine Henrichson; Szuhai, K; Heslanyeth Barragan Polania, Ana; Rydbeck, Kjell Erik Halfdan; Cleton-Jansen, A. M.; Myklebost, Ola; Meza, Leonardo Zepeda. 2010. Evaluation of high-resolution microarray platforms for genomic profiling of bone tumours. BMC Research Notes. 3: 223. doi: 10.1186/1756-0500-3-223
  • Mayordomo, E; Machado, I; Giner, F; Kresse, Stine Henrichson; Myklebost, Ola; Carda, C; Navarro, S; LLombart-Bosch, A. 2010. A Tissue Microarray Study of Osteosarcoma: Histopathologic and Immunohistochemical Validation of Xenotransplanted Tumors as Preclinical Models. Applied immunohistochemistry & molecular morphology (Print). 18: 453-461. doi: 10.1097/PAI.0b013e3181daace3
  • Muller, Christoph Rainer; Namløs, Heidi Maria; Bjerner, Johan; Østensen, Ingrid Helene Garmann; Sæter, Gunnar; Smeland, Sigbjørn; Bruland, Øyvind; Myklebost, Ola. 2010. Characterization of Treatment Response to Recombinant Interferon-α2b in Osteosarcoma Xenografts. Journal of Cancer Science & Therapy. 2: 16-25. doi: 10.4172/1948-5956.1000018
  • Namløs, Heidi Maria; Kresse, Stine Henrichson; Østensen, Ingrid Helene Garmann; Duim, Ronald A.J.; Cleton-Jansen, Anne-Marie; Meza, Leonardo Zepeda; Myklebost, Ola. 2010. Integrated analysis reveals overexpression of miRNA clusters in osteosarcomas. European Journal of Cancer. 8: 206-207.
  • Ottaviano, L; Schaefer, K-L; Gajewski, M; Huckenbeck, W; Baldus, S; Rogel, U; Mackintosh, C; de Alava, E; Myklebost, Ola; Kresse, Stine Henrichson; Meza, Leonardo Zepeda; Serra, M; Cleton-Jansen, A. M.; Hogendoorn, PCW; Buerger, H; Aigner, Thomas; Gabbert, HE; Poremba, C. 2010. Molecular Characterization of Commonly Used Cell Lines for Bone Tumor Research: A Trans-European EuroBoNet Effort. Genes, Chromosomes and Cancer. 49: 40-51. doi: 10.1002/gcc.20717
  • Tenstad, Ellen; Tourovskaia, Anna; Folch, Albert; Myklebost, Ola; Rian, Edith. 2010. Extensive adipogenic and osteogenic differentiation of patterned human mesenchymal stem cells in a microfluidic device. Lab on a Chip. 10: 1401-1409. doi: 10.1039/b926738g
  • Kresse, Stine Henrichson; Ohnstad, HO; Paulsen, Erik Braarød; Bjerkehagen, Bodil; Szuhai, K; Serra, M.; Schaefer, K-L; Myklebost, Ola; Meza, Leonardo Andres Zepeda. 2009. LSAMP, a Novel Candidate Tumor Suppressor Gene in Human Osteosarcomas, Identified by Array Comparative Genomic Hybridization. Genes, Chromosomes and Cancer. 48: 679-693. doi: 10.1002/gcc.20675
  • Lehne, Gustav; Grasmo-Wendler, Unn-Hilde; Berner, Jeanne-Marie; Meza, Leonardo Andres Zepeda; Adamsen, Birgitte Lid; Flack, Aksel; Reiner, Andrew Henry; Clausen, Ole Petter Fraas; Hovig, Eivind; Myklebost, Ola. 2009. Upregulation of stem cell genes in multidrug resistant K562 leukemia cells. Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis. 33: 1379-1385. doi: 10.1016/j.leukres.2009.03.028
  • Ottaviano, L; Schaefer, K-L; Gajewski, M; Huckenbeck, W; Baldus, S; Rogel, U; Mackintosh, C; de Alava, E; Myklebost, Ola; Kresse, Stine Henrichson; Meza, Leonardo Andres Zepeda; Serra, M.; Cleton-Jansen, A. M.; Hogendorn, PCW; Buerger, H; Gabbert, HE; Poremba, C. 2009. Molecular characterization of commonly used cell lines for bone tumor research. A trans-European EuroBoNet effort. Genes, Chromosomes and Cancer. 49: 40-51.
  • Kresse, Stine Henrichson; Skårn, Magne; Ohnstad, Hege Oma; Namløs, Heidi Maria; Bjerkehagen, Bodil; Myklebost, Ola; Meza, Zepeda Leonardo. 2008. DNA copy number changes in high-grade malignant peripheral nerve sheath tumors by array CGH. Molecular Cancer. 7. 11 sider. doi: 10.1186/1476-4598-7-48
  • Lyng, H; Lando, M; Brovig, RS; Svendsrud, DH; Johansen, M; Galteland, E; Brustugun, OT; Meza, Zepeda Leonardo; Myklebost, Ola; Kristensen, Gunnar S Balle; Hovig, Eivind; Stokke, T. 2008. GeneCount: genome-wide calculation of absolute tumor DNA copy numbers from array comparative genomic hybridization data. Genome Biology. 9: R86. doi: 10.1186/gb-2008-9-5-r86
  • Meza, Zepeda Leonardo; Noer, Agate; Dahl, John Arne; Micci, F; Myklebost, Ola; Collas, Philippe. 2008. High-resolution analysis of genetic stability of human adipose tissue stem cells cultured to senescence. Journal of Cellular and Molecular Medicine. 12: 553-563. doi: 10.1111/j.1582-4934.2007.00146.x
  • Myklebost, Ola. 2008. Det internasjonale kreftgenomprosjektet. Genialt.
  • Roman, E; Meza, Leonardo Andres Zepeda; Kresse, Stine Henrichson; Myklebost, Ola; Vasstrand, EN; Ibrahim, SO. 2008. Chromosomal aberrations in head and neck squamous cell carcinomas in Norwegian and Sudanese populations by array comparative genomic hybridization. Oncology Reports. 20: 825-843.
  • Roman, Eric; Meza-Zepeda, Leonardo A.; Kresse, Stine H.; Myklebost, Ola; Vasstrand, Endre N.; Ibrahim, Salah Osman. 2008. Chromosomal aberrations in head and neck squamous cell carcinomas in Norwegian and Sudanese populations by array comparative genomic hybridization. Oncology Reports. 20: 825-843. doi: 10.3892/or_00000080
  • Francis, P; Namlos, HM; Muller, C; Eden, P; Fernebro, J; Berner, JM; Bjerkehagen, B; Akerman, M; Bendahl, PO; Isinger, A; Rydholm, A; Myklebost, Ola; Nilbert, M. 2007. Diagnostic and prognostic gene expression signatures in 177 soft tissue sarcomas: hypoxia-induced transcription profile signifies metastatic potential. BMC Genomics. 8. doi: 10.1186/1471-2164-8-73
  • Kleivi, Kristine; Lind, Guro E; Diep, Chieu B; Meling, Gunn I; Brandal, Lin Thorstensen; Nesland, Jahn M; Myklebost, Ola; Rognum, Torleiv; Giercksky, Karl-Erik; Skotheim, Rolf I; Lothe, Ragnhild A. 2007. Gene expression profiles of primary colorectal carcinomas, liver metastases, and carcinomatoses. Molecular Cancer. 6. 16 sider. doi: 10.1186/1476-4598-6-2
  • Muller, CR; Paulsen, EB; Noordhuis, P; Pedeutour, F; Soeter, G; Myklebost, Ola. 2007. Potential for treatment of liposarcomas with the MDM2 antagonist Nutlin-3A. International Journal of Cancer. 121. doi: 10.1002/ijc.22643
  • Berner, Jeanne-Marie; Muller, Christoph Rainer; Holden, Marit; Wang, Junbai; Hovig, Eivind; Myklebost, Ola. 2006. Sampling effects on gene expression data from a human tumour xenograft. Scandinavian Journal of Laboratory Animal Science. 33: 17-34.
  • Meza, Zepeda Leonardo; Kresse, Stine Henrichson; Barragan-Polania, AH; Bjerkehagen, B; Ohnstad, HO; Namlos, HM; Wang, JB; Kristiansen, Bjørn Evert; Myklebost, Ola. 2006. Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas. Cancer Research. 66: 8984-8993.
  • Meza-Zepeda, L. A.; Kresse, Stine Henrichson; Barragan-Polania, AH; Bjerkehagen, Bodil; Ohnstad, Hege Oma; Namløs, Heidi Maria; Wang, Junbai; Kristiansen, B. E.; Myklebost, Ola. 2006. Array comparative genomic hybridization reveals distinct DNA copy number differences between gastrointestinal stromal tumors and leiomyosarcomas. Cancer Research. doi: 10.1158/0008-5472.CAN-06-1972
  • Bjerkehagen, Bodil; Myklebost, Ola. 2005. Molekylærbiologisk diagnostikk ved bein- og bløtvevssvulster. Tidsskrift for Den norske legeforening. 125: 3286-3289.
  • Galteland, Eivind; Sivertsen, EA; Svendsrud, D.H; Smedshammer, L.; Kresse, Stine Henrichson; Meza-Zepeda, Leonardo A.; Myklebost, Ola; Suo, Zhenhe; Mu, D; DeAngelis, PM; Stokke, Trond. 2005. Translocation t(14;18)and gain of chromosome 18/BCL2: effects on BCL2 exression and apoptosis in B-cell non-Hodgkin's lymphomas. Leukemia. 19: 2313-2323. doi: 10.1038/sj.leu.2403954
  • Kresse, Stine Henrichson; Berner, Jeanne-Marie; Meza-Zepeda, Leonardi A; Gregory, Simon G; Kuo, Wen-Lin; Gray, Joe; Forus, Anne; Myklebost, Ola. 2005. Mapping and characterizatin of the amplicon near APOA2 in Iq23 in human sarcomas by FISH and array CGH. Molecular Cancer. 4: 39-50. doi: 10.1186/1476-4598-4-39
  • Nygaard, Vigdis; Holden, Marit; Løland, Anders; Langaas, Mette; Myklebost, Ola; Hovig, Eivind. 2005. Limitations of mRNA amplification from small-size cell samples. BMC Genomics. 6. 147. doi: 10.1186/1471-2164-6-147
  • Roman, Eric; Meza-Zepeda, Leonardo A.; Kresse, Stine H.; Myklebost, Ola; Vasstrand, Endre N.; Ibrahim, Salah Osman. 2005. Genome-Wide Screening of DNA Copy Number and Chromosomal Alterations in Oral Squamous Cell Carcinomas by Micro Array Comparative Genomic Hybridizations. European Journal of Medical Genetics. 48: 513-514.
  • Ågesen, T.H; Flørenes, Vivi Ann; Molenaar, I.; Lind, Gruo Elisabeth; Berner, JM; Plaat, BEC; Komdeur, R; Myklebost, Ola; van den Berg, E; Lothe, Ragnhild A. 2005. Expression patterns of cell cycle components in sporadic and neurofibromatosis type 1 related malignant peripheral nerve sheath tumors. Journal of Neuropathology and Experimental Neurology. 64: 74-81.
  • Haug, O; Myklebost, Ola; Aldrin, M; Østenstad, Bjørn; Holden, M; Frigessi, Arnoldo; Sioud, Mouldy; Cekaite, Lina; Hovig, Eivind. 2004. Analysis of the humoral immune response to immunoselected phage-displayed peptides by a microarray-based method. Proteomics. 4: 2572-2582.
  • Lyng, Heidi; Badiee, Azadeh; Svendsrud, Debbie H.; Hovig, Eivind; Myklebost, Ola; Stokke, Trond. 2004. Profound influence of microarray scanner characteristics on gene expression ratios: analysis and procedure for correction. BMC Genomics. 5: 10.
  • Lyng, Heidi; Landsverk, Kirsti; Kristiansen, Elin; de Angelis, Paula; Ree, Anne Hansen; Myklebost, Ola; Hovig, Eivind; Stokke, Trond. 2004. The response of malignant B lymphocytes to ionizing radiation: Geneexpression and genotype. International Journal of Cancer. 115: 935-942.
  • Troen, Gunhild; Nygaard, Vigdis; Jenssen, T. K.; Ikonomou, I.M; Tierens, Anne; Matutes, Estella; Gruszka-Westwood, A; Catovsky, D; Myklebost, Ola; Lauritzen, G; Hovig, Eivind; Delabie, Jan. 2004. Constitutive expression of the AP-1 transcription factors c-jun, junD, junB and c-fos and the marginal zone B-cell transcription factor Notch2 in splenic marginal zone lymphoma. Journal of Molecular Diagnostics. 6: 297-307.
  • Wang, Junbai; Bø, Trond Hellem; Bo, TH; Jonassen, Inge; Myklebost, Ola; Hovig, Johannes Eivind; Hovig, Eivind. 2004. Tumor classification and marker gene prediction by feature selection and fuzzy c-means clustering using microarray data. BMC Bioinformatics. 4: art. no.-60.
  • Wang, Junbai; Meza, Zepeda Leonardo; Kresse, Stine Henrichson; Myklebost, Ola. 2004. M-CGH: Analysing microarray-based CGH experiments. BMC Bioinformatics. 5: art. no.-74. doi: 10.1186/1471-2105-74
  • Wang, Junbai; Meza-Zepeda, LA; Kresse, Stine Henrichson; Myklebost, Ola. 2004. M-CGH: analysing microarray-based CGH experiments. BMC Bioinformatics. doi: 10.1186/1471-2105-5-74
  • Andersen, Kristin; Smith-Sørensen, Birgitte; Pedersen, Kjetil Boye; Hovig, Eivind; Myklebost, Ola; Fodstad, Øystein; Mælandsmo, Gunhild Mari. 2003. Interferon-gamma suppresses S100A4 transciption independently of apoptosis or cell cycle arrest. British Journal of Cancer. 88: 1995-2001.
  • Henriksen, Jørn; Aagesen, T.H.; Mælandsmo, Gunhild Mari; Lothe, Ragnhild A; Myklebost, Ola; Forus, Anne. 2003. Amplification and overexpression of COPS3 in osteosarcomas potentially target TP53 for proteasome-mediated degradation. Oncogene. 22: 5358-5361.
  • Maire, G.; Forus, Anne; Foa, C; Bjerkhagen, B.; Mainguene, C.; Kresse, Stine Henrichson; Myklebost, Ola; Pedeutour, Florence. 2003. 11q13 alterations in two cases of hibernoma: large heterozygous deletions and rearrangement breakpoints near GARP in 11q13.5. Genes, Chromosomes and Cancer. 20: 389-395.
  • Nygaard, Vigdis; Løland, Anders; Holden, Marit; Langaas, Mette; Rue, Håvard; Liu, Fang; Myklebost, Ola; Fodstad, Øystein; Hovig, Eivind; Smith-Sørensen, Birgitte. 2003. Effects of mRNA amplification on gene expression ratios in cDNA experiments estimated by analysis of variance. BMC Genomics. 4. doi: 10.1186/1471-2164-4-11
  • Wang, Junbai; Bø, Trond Hellem; Jonasen, Inge; Myklebost, Ola; Hovig, Eivind. 2003. Tumor classification and marker gene prediction by feature selection and fuzzy c-means clustering using microarray data. BMC Bioinformatics. 4: 60. Publisert 2003-12-02.
  • Wang, Junbai; Bø, Trond; Jonassen, Inge; Myklebost, Ola; Hovig, Eivind. 2003. Tumor classification and marker gene prediction by feature selection and fuzzy c-means clustering using microarray data. BMC Bioinformatics. 4: 60.
  • Wang, Junbai; Myklebost, Ola; Hovig, Eivind. 2003. MGraph: graphical models for microarray data analysis. Bioinformatics. 19: 2210-2211.
  • Wang, Junbai; Myklebost, Ola; Hovig, Eivind; Henriksen, Jørn; Mælandsmo, Gunhild Mari; Lothe, Ragnhild A; Forus, Anne; Kresse, Stine Henrichson; Andersen, Kristin; Smith-Sørensen, Birgitte; Pedersen, Kjetil Boye; Fodstad, Øystein; Nygaard, Vigdis; Liu, Fang. 2003. Tumor classification and marker gene prediction by feature selection and fuzzy c-means clustering using microarray data. BMC Bioinformatics. 4: 60.
  • Jenssen, Tor-Kristian; Langaas, Mette; Kuo, W.P.; Smith-Sørensen, Birgitte; Myklebost, Ola; Hovig, Eivind. 2002. Analysis of repeatability in spotted cDNA microarrays. Nucleic Acids Research. 14: 3235-3244.
  • Jenssen, Tor-Kristian; Langaas, Mette; Kuo, Winston P.; Smith-Sørensen, Birgitte; Myklebost, Ola; Hovig, Eivind. 2002. Analysis of repeatability in spotted cDNA microarrays. Nucleic Acids Research. 30: 3235-3244. doi: 10.1093/nar/gkf441
  • Meza-Zepeda, Leonardo A.; Forus, Anne; Lygren, B.; Dahlberg, A. B.; Godager, Linda H.; South, A.; Marenholz, I.; Flørenes, Vivi Ann; Mælandsmo, Gunhild Mari; Serra, M.; Mischke, D.; Nezetic, D.; Ragoussis, I.; Tarkkanen, M.; Nesland, Jahn M; Myklebost, Ola. 2002. Positional cloning identifies a novel cyclophilin as a candidate amplified oncogene in 1q21. Oncogene. 21: 2261-2269.
  • Wang, Jacob Edward; Delabie, Jan; Aasheim, Hans-Christian; Myklebost, Ola. 2002. Clustering of the SOM easily reveals distinct gene expression patterns:results of a reanalysis of lymphoma study. BMC Cell Biology. 1: 36-36.
  • Wang, Jacob Edward; Delabie, Jan; Aasheim, Hans-Christian; Smeland, Erlend B; Myklebost, Ola. 2002. Clustering of the SOM easily reveals distinct gene expression patterns: results of a reanalysis of lymphoma study. Bioinformatics. 3: 36.
  • Wang, Junbai; Delabie, Jan; aasheim, Hans-Christian; Smeland, Erlend B; Myklebost, Ola. 2002. Clustering of the SOM easily reveals distinct gene expression patterns: results of a reanalysis of lymphoma study. BMC Bioinformatics.
  • Xie, Y.; Skytting, B.; Nilsson, G.; Grimer, R.J.; Mangham, C.D.; Fisher, C.; Shipley, J.; Bjerkehagen, Bodil; Myklebost, Ola; Larsson, O. 2002. The SYT-SSX1 fusion type of synovial sarcoma is associated with increased expression of cyclin A and D1. A link between t(X;18)(p11.2;q11.2)and the cell cycle machinery. Oncogene. 37: 5791-5796.
  • Xie, Y.; Skytting, B.; Nilsson, G.; Grimer, R.J.; Mangham, C.D.; Fisher, C.; Shipley, J.; Bjerkehagen, Bodil; Myklebost, Ola; Larsson, O. 2002. The SYT-SSX1 fusion type of synovial sarcoma is associated with increased expression of cyclin A and D1. A link between t(X;18)(p11;2;q11.2) and the cell cycle machinery. Oncogene. 21: 5791-5796.
  • Forus, Anne; Bjerkhagen, B.; Sirvent, N.; Meza-Zepeda, Leonardo A.; Coindre, J.M.; Berner, Jeanne-Marie; Myklebost, Ola; Pedeutour, Florence. 2001. A well-differentiated liposarcoma with a new type of chromosome 12-derived markers. Cancer Genetics and Cytogenetics. 131: 13-18.
  • Forus, Anne; Larramedny, M. L.; Meza-Zepeda, Leonardo A.; Bjerkehagen, Bodil; Godager, Linda H.; Dahlberg, A. B.; Sæter, Gunnar; Knuutila, S.; Myklebost, Ola. 2001. Dedifferentiation of a well-differentiated liposarcoma to a highly malignant metastatic osteosarcoma: amplification of 12q14 at all stages and gain of 1q22-q24 associated with metastases. Cancer Genetics and Cytogenetics. 125: 100-111.
  • Forus, Anne; Larramedny, M. L.; Meza-Zepeda, Leonardo A.; Bjerkehagen, Bodil; Godager, Linda H.; Dahlberg, A. B.; Sæter, Gunnar; Knuutila, S.; Myklebost, Ola. 2001. Dedifferentiation of a well-differentiated liposarcoma to a highly malignant osteosarcoma:amplification of 12q14 at all stages and gain of 1q22-q24 associated with metastases. Cancer Genetics and Cytogenetics. 125: 100-111.
  • Forus, Anne; Meza-Zepeda, Leonardo A.; Bjerkhagen, B.; Godager, Linda H.; Dahlberg, A. B.; Knuutila, S.; Myklebost, Ola. 2001. Dedifferentiation of a WDLPS to a highly malignant osteogenic tumor is associated with high-level amplification og 12q14-q22 and gain of 1q22. Cancer Genetics and Cytogenetics. 125(5): 100-111.
  • Forus, Anne; Sørlie, Therese; Børresen-Dale, Anne-Lise; Myklebost, Ola. 2001. Mikromatriser i kreftforskning: Nå trenger vi ikke å bare lete under gatelyktene! Tidsskrift for Den norske legeforening. 121: 2498-2503.
  • Hovig, Eivind; Myklebost, Ola; Aamdal, Steinar; Smeland, Erlend B. 2001. Genterapi ved kreft. Tidsskrift for Den norske legeforening. 121: 482-488.
  • Lægreid, A.; Komorowski, J.; Sandvik, Arne K.; Hovig, Eivind; Forus, Anne; Smith-Sørensen, Birgitte; Beisvag, Vidar; Kristiansen, B.; Nørsett, K.; Nygaard, Vegard; Støren, O.; Myklebost, Ola. 2001. DNA mikroarray- vindu mot tusentals gen. NBS-nytt. 1: 482-488.
  • Sandvik, Arne K.; Støren, O.; Nørsett, K.; Børresen-Dale, Anne-Lise; Lægreid, A.; Myklebost, Ola. 2001. Måling av genaktivitet med DNA mikromatriser (mikroarray). Molekylære og teknologiske prinsipper. Tidsskrift for Den norske legeforening. 121: 1225-1228.
  • Sandvik, Arne K.; Støren, Ole; Nørsett, Kristin; Børresen-Dale, Anne-Lise; Lægreid, Astrid; Myklebost, Ola. 2001. Måling av genaktivitet med DNA mikromatriser (mikroarray). Molekylære og teknologiske prinsipper. Tidsskrift for Den norske legeforening. 121: 1225-1228.
  • Forus, Anne; Larramedny, M. L.; Meza-Zepeda, Leonardo A.; Bjerkhagen, B.; Godager, Linda H.; Dahlberg, A. B.; Knuutila, S.; Myklebost, Ola. 2000. Dedifferentiation of a WDLPS to a highly malignant osteogenic tumor is associated with high-level amplification of 12q14-q22 and gain of 1q22. Cancer Genetics and Cytogenetics.
  • Hovig, Eivind; Myklebost, Ola. 2000. Menneskets DNA ferdig kartlagt. Klassekampen.
  • Meza-Zepeda, Leonardo A.; Berner, Jeanne-Marie; South, A.; Henriksen, J.; Dahlberg, A. B.; Godager, Linda H.; Pedeutour, Florence; Nizetic, D.; Forus, Anne; Myklebost, Ola. 2000. Characterisation of etopic sequences from tumor-associated, truncated HMGIC genes shows recurrent involvement of spesific chromosomal regions. Genes, Chromosomes and Cancer.
  • Sandvik, Arne K.; Støren, O.; Nørsett, K.; Børresen-Dale, Anne-Lise; Lægreid, A.; Myklebost, Ola. 2000. DNA Mikroarray- molekylære og teknologiske prinsipper. Tidsskrift for Den norske legeforening.
  • Simons, A.; Jeuken, J.; Zande, G. van de; Bjerkehagen, Bodil; Forus, Anne; Weibolt, V.; Molenaar, I.; Berg, E. van den; Myklebost, Ola; Bridge, J.; Kessel, A. Geurts van; Suijkerbuijk, R.; Schepens, M.; Sprenger, S. 2000. Frequent allelic loss of 9p21 (p16INK4A) and other genomic imbalances in human malignant fibruos histiocytoma. Cancer Genetics and Cytogenetics. 89-98.
  • Simons, A.; Schepens, M.; Jeuken, J.; Sprenger, S.; Zande, G. van de; Bjerkehagen, Bodil; Forus, Anne; Weibolt, V.; Molenaar, I.; Berg, E. van den; Myklebost, Ola; Bridge, J.; Kessel, A. Geurts van; Suijkerbuijk, R. 2000. Frequent allelic loss of 9p21 (p16INK4A) and other genomic imbalances in human malignant fibruos histiocytoma. Cancer Genetics and Cytogenetics. in press.
  • Sirvent, N.; Forus, Anne; Lescaut, W.; Burel, F.; Benzaken, S.; Chazal, M.; Bourgeon, A.; Vermeesch, J.; Myklebost, Ola; Turc-Carel, C.; Ayraud, N.; Coindre, J.M.; Pedeutour, Florence. 2000. Characterization of centromere alterations in liposarcomas. Genes, Chromosomes and Cancer. 117-129.
  • Sirvent, N.; Forus, Anne; Lescaut, W.; Burel, F.; Benzaken, S.; Chazal, M.; Bourgeon, A.; Vermeesch, J.; Myklebost, Ola; Turc-Carel, C.; Ayraud, N.; Coindre, J.M.; Pedeutour, Florence. 2000. Characterization of centromere alterations in liposarcomas. Genes, Chromosomes and Cancer. 117-129.
  • Berner, Jeanne-Marie; Sørlie, Therese; Mertens, F.; Henriksen, J.; Sæter, Gunnar; Mandahl, N.; Brøgger, Anton; Myklebost, Ola; Lothe, Ragnhild A. 1999. Chromosome band 9p21 is frequently altered in malignant peripheral nerve sheath tumors from patients with neurofibromatosis type 1. Studies of CDKN2A and other genes og the pRB pathway. Genes, Chromosomes and Cancer. 151-160.
  • Forus, Anne; Høifødt, H. K.; Øverli, G. E. T.; Myklebost, Ola; Fodstad, Øystein. 1999. Sensitive method for FISH chracterisation of breast cancer cells in bone marrow aspirates. Molecular Pathology. 52: 68-74.
  • Myklebost, Ola. 1999. Bioteknologiloven og medisinsk forskning. Aftenposten (morgenutg. : trykt utg.).
  • Pedeutour, Florence; Forus, Anne; Coindre, J.M.; Berner, Jeanne-Marie; Nicolo, G.; Michiels, J-F.; Terrier, P.; Bain, C. A.; Collin, F.; Myklebost, Ola; Turc-Carel, C. 1999. Structure of ring and giant rod marker chromosomes in adipose tissue tumors: A study combining fluorescent in situ hybridization, comparative genomic hybridization, molecular analyses and immunohistochemistry. Genes, Chromosomes and Cancer. 24: 30-41.
  • Simons, A.; Schepens, M.; Forus, Anne; Godager, Linda H.; Asseldonk, M. van; Myklebost, Ola; Kessel, A. Geurts van. 1999. A novel chromosomal region of allelic loss, 4q32-q34, in human osteosarcomas revealed by representational difference analysis. Genes, Chromosomes and Cancer. 26: 115-120.
  • Wolf, Mark J. P.; Tarkkanen, M.; Hulsebos, T.; Larramedny, M. L.; Forus, Anne; Myklebost, Ola; Aaltonen, L. A.; Elomaa, I.; Knuutila, S. 1999. Characterization of the 17p amplicon inhuman sarcomas - microsatellite marker analysis. International Journal of Cancer. 82: 329-333.
  • Forus, Anne; Berner, Jeanne-Marie; Meza-Zepeda, Leonardo A.; Mischke, D.; Fodstad, Øystein; Myklebost, Ola. 1998. Molecular characterisation of a novel amplicon at 1q21-q22 in human sarcomas. British Journal of Cancer. 78: 495-503.
  • Myklebost, Ola. 1998. Richard Seed vil klone mennesker. VG : Verdens gang.
  • Armengol, G.; Tarkkanen, M.; Virolainen, M.; Forus, Anne; Valle, Jo Helle; Bohling, T.; Asko-Seljavaara, S.; Blomquist, Carl; Elomaa, I.; Karaharju, E.; Kivioja, A.H.; Siimes, Martti A.; Tukiainen, E.; Caballin, M.R.; Myklebost, Ola; Knuutila, S. 1997. Recurrent gains of 1q, 8 and 12 in the Ewing family of tumors by cemparative genomic hybridisation. British Journal of Cancer. 75: 1403-1409.
  • Berner, Jeanne-Marie; Kools, Patrick F.J.; Forus, Anne; Schoenmakers, E.F.P.M.; Ven, W. J. M. van de; Meza-Zepeda, Leonardo A.; Fodstad, Øystein; Myklebost, Ola. 1997. HMGIC, the gene for an architectural transcription factor, is amplified and rearranged in a subset of human sarcomas. Oncogene. 14: 2935-2941.
  • Kessel, A. Geurts van; Santos, N. R. Dos; Simons, A.; Bruijn, D. De; Forus, Anne; Fodstad, Øystein; Myklebost, Ola; Balemans, M.; Baats, E.; Weghuis, D. Olde; Suijkerbuijk, R.; Leuw, B. De. 1997. Cytogenetics and molecular genetics of bone and soft tissue tumours. Cancer Genetics and Cytogenetics. 95: 67-73.
  • Myklebost, Ola. 1997. Kloningsdebatt på rett spor. Dagbladet.
  • Myklebost, Ola. 1997. Ingen etiske betenkeligheter. VG : Verdens gang.
  • Myklebost, Ola. 1997. Vil forby kloning av mennesker. Vårt land.
  • Myklebost, Ola. 1997. Fremtiden med Dolly. Aftenposten (morgenutg. : trykt utg.).
  • Wolf, Mark J. P.; Aaltonen, L. A.; Szymanska, Jadwiga; Tarkkanen, M.; Blomquist, Carl; Berner, Jeanne-Marie; Myklebost, Ola; Knuutila, S. 1997. Complexity of 12q13-22 amplicon in liposarcoma: Microsatellite repeat analysis. Genes, Chromosomes and Cancer. 18: 66-70.
  • Berner, Jeanne-Marie; Forus, Anne; Kahloun, A.E.; Meltzer, P.S.; Fodstad, Øystein; Myklebost, Ola. 1996. Separate amplified regions encompassing CDK4 and MDM2 in human sarcomas. Genes, Chromosomes and Cancer. 17: 254-259.
  • Myklebost, Ola. 1996. First for biotech. Nature. 384: 208.
  • Mælandsmo, Gunhild Mari; Hovig, Eivind; Skrede, Martina; Engebråten, Olav; Flørenes, Vivi Ann; Myklebost, Ola; Grigorian, M.S.; Lukanidin, E.; Fodstad, Øystein. 1996. Reversal of the in vivo metastatic phenotype of human tumor cells by an anti-CAPL (mts-1) ribozyme. Cancer Research. 5490: 5490-5498.
  • Kulseth, Mari Ann; Krajci, Peter; Myklebost, Ola; Rogne, Sissel. 1995. Cloning and Characterization of Two Forms of Bovine Polymeric Immunoglobulin Receptor cDNA. DNA and Cell Biology. 14: 251-256.
  • Mælandsmo, Gunhild Mari; Berner, Jeanne-Marie; Flørenes, Vivi Ann; Forus, Anne; Hovig, Eivind; Fodstad, Øystein; Myklebost, Ola. 1995. Homozygous deletion frequency and expression levels of the CDKN2 gene in human sarcomas - relationship to amplification and mRNA levels of CDK4 and CCND1. British Journal of Cancer. 72: 393-398.
  • Flørenes, Vivi Ann; Holm, Ruth; Lendahl, U.; Myklebost, Ola; Fodstad, Øystein. 1994. Expression of the neuroectodermal intermediate filament nestin in human melanomas. Cancer Research. 54: 354-356.
  • Forus, Anne; Flørenes, Vivi Ann; Mælandsmo, Gunhild Mari; Fodstad, Øystein; Myklebost, Ola. 1994. The protooncogene CHOP/GADD153, involved in growth arrest and DNA damage response, is amplified in a subset of human sarcomas. Cancer Genetics and Cytogenetics. 78: 165-171.
  • Forus, Anne; Flørenes, Vivi Ann; Mælandsmo, Gunhild Mari; Meltzer, P.S.; Fodstad, Øystein; Myklebost, Ola. 1993. Mapping of amplification units in the q13-14 region of chromosome 12 in human sarcomas: Some amplica do not include MDM2. Cell growth & differentiation. 4: 1065-1070.
  • Flørenes, Vivi Ann; Aamdal, Steinar; Myklebost, Ola; Mælandsmo, Gunhild Mari; Bruland, Øyvind; Fodstad, Øystein. 1992. Levels of mm23 mRNA in metastatic malignant melanomas. Inverse correlation to disease progression. Cancer Research. 52: 6088-6091.
  • Skrede, Bjørn; Blomhoff, Rune; Mælandsmo, Gunhild Mari; Ose, Leiv; Myklebost, Ola; Norum, Kaare Reidar. 1992. Uptake of chylomicron remnant retinyl esters in human leukocytes in vivo. European J. Clin.. 229-234.
Rapporter/avhandlinger
  • Kresse, Stine Henrichson; Myklebost, Ola. 2008. Chromosomal aberrations in human sarcomas identified using genomic microarrays. 78 sider.
  • Mælandsmo, Gunhild Mari; Fodstad, Øystein; Grigorian, M.S.; Hovig, Eivind; Kashani-Sabet, M.; Lukadin, E.M.; Myklebost, Ola. 1996. Reversal of the in vivo metastatic phenotype of human osteosarcoma cells by an anti-CAPL (Mts-1) ribozyme. Det norske Radiumhospital. -1 sider.
  • Flørenes, Vivi Ann; Holm, Ruth; Lendahl, U.; Myklebost, Ola; Fodstad, Øystein. 1994. Expression of the neuroectodermal intermediate filament nestin in human melanomas. 3 sider.
  • Flørenes, Vivi Ann; Mælandsmo, Gunhild Mari; Forus, Anne; Andreassen, Å.; Myklebost, Ola; Fodstad, Øystein. 1994. MDM2 gene amplification and transcript levels in human sarcomas - Relationship to p53 status. Det norske Radiumhospital. 6 sider.
Bokkapitler
  • Myklebost, Ola. 2015. Gener og kreft. Gener og kreft, sider 247-263. I:
    • Hessen, Dag Olav; Lie, Thore; Stenseth, Nils Christian. 2015. Mendels arv - Genetikkens æra. Gyldendal Norsk Forlag A/S. 440 sider. ISBN: 978-82-05-45818-5.
  • Myklebost, Ola. 2009. Stamcellenes mørke side. Kapittel, sider 165-175. I:
    • Hobson, Anette. 2009. P2 akademiet XLI. 189 sider. ISBN: 978-82-7596-165-3.
  • Smeland, Erlend B; Prydz, Hans Peter B; Ørstavik, Karen Helene; Frøland, Stig Sophus; Aamdal, Steinar; Myklebost, Ola; Apold, J; Børresen-Dale, Anne-Lise; Seeberg, Erling Christen; Hovig, Eivind; Krokan, Hans E.; Berg, K. Andersen; Attramadal, Håvard; Solbakk, Jan Helge; Lyngstadaas, Anita. 2000. Genterapi. Status og fremtidige muligheter innen klinisk medisin. I:
    • 2000. Tidlig identifikasjon og vurdering av nye metoder. Senter for medisinsk metodevurdering. -1 sider.
  • Myklebost, Ola. 1999. Undersøker tusenvis av gener. I:
    • 1999. Mot Kreft. -1 sider.

Se fullstendig oversikt over publikasjoner i CRIStin.